SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-05-004892
Filing Date
2005-02-09
Accepted
2005-02-09 14:22:29
Documents
2
Group Members
AVENTIS HOLDINGS INCAVENTIS INC.AVENTIS PHARMACEUTICALS INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G a05-2856_3sc13g.htm SC 13G 121811
2 EX-1 a05-2856_3ex1.htm EX-1 17900
  Complete submission text file 0001104659-05-004892.txt   141948
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-47221 | Film No.: 05588089
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 174 AVENUE DE FRANCE PARIS I0 75013
Business Address 174 AVENUE DE FRANCE PARIS I0 75013 33153774400
SANOFI-AVENTIS (Filed by) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations